优越的基于片段的设计,合成和体外抗瘤活性的伊马替尼比类似物

Hongyu Jiang1, Yuankun Wang1, Maokai Jiang1

  • 1School of Pharmacy, Collaborative Innovation Center of Advanced Drug Delivery System and Biotech Drugs in Universities of Shan-dong, Key Laboratory of Molecular Pharmacology and Drug Evaluation (Yantai University), Ministry of Education, Yantai University, Yantai, China.

PubMed
概括

研究人员使用基于片段的药物设计设计设计了新型伊马替尼比类似物. 最强效的化合物I2对人类髓性白血病和对伊马替尼布耐药癌细胞表现出优异的抗瘤活性.